Home › NDC Lookup › Ingredients › Wart Remover › 63347-0720-01
📦image loading
(from DailyMed)

VERUCIDE WART REMOVER Kit Kit — NDC 63347-720-01 (Billing 63347-0720-01)

by Blaine Labs Inc. · 1 KIT in 1 PACKAGE * 3 mL in 1 BOTTLE * 7.5 mL in 1 BOTTLE

This is a package of VERUCIDE WART REMOVER Kit Kit from Blaine Labs Inc., marketed since Sep 2023 and currently FDA-listed. It is this product's only package size.

NDC 63347-0720-01
🏷️ FDA NDC (as labeled) 63347-720-01 billing pads the product segment with a zero
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 63347-720-01
Product NDC 63347-720
11-digit billing NDC 63347072001
RxCUI 312881, 1039483
Application # M028
SPL Set ID 017f3ca2-6dba-4db5-b559-8ce0f2709772
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2023-09-29
Dosage form KIT
Quick answers
  • RxCUI (RxNorm): 312881
Why two NDCs? The FDA registers this code as 63347-720-01 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 63347-0720-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Salicylic acid and derivatives class.

Drug family (ATC) Salicylic acid and derivatives, Other antifungals for topical use, Antiinflammatory agents, non-steroids
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

🧪 What is this product?

Verucide Wart Remover Kit is an over-the-counter topical product marketed under FDA's OTC monograph rules for wart removal. The kit typically contains salicylic acid, a keratolytic agent commonly used to soften and help shed the thickened skin that makes up a wart. This product is intended for external use on the skin to address common warts.

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eachPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
63347-0720-01 You're viewing this Main listing 1 KIT in 1 PACKAGE * 3 mL in 1 BOTTLE * 7.5 mL in 1 BOTTLE 2023-09-29 — Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
VERUCIDE WART REMOVER Kitthis 63347-0720-01 Blaine 1 kit — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2023
On the market since
Sep 2023
📍
2026
Currently FDA-listed
3 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

From the label’s inactive-ingredient sectionInactive Ingredients (for step 1) Glycerin, Hydroxypropyl Cellulose, Lavandula Angustifolia (Lavender) Flower Extract, Purified Water (for step 2) Alcohol (Ethanol), Artemisia Absinthium (Wormwood) Extract, Carica Papaya (Papaya) Fruit Extract, Glycerin, Hydroxypropyl Cellulose, Purified Water

This is label-wide narrative text, not a normalized exact-product ingredient list. A label can cover multiple strengths or packages.

Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerBlaine Labs Inc.
FDA applicationM028 (OTC MONOGRAPH DRUG)
Labeler code63347
First marketedSep 2023
Product typeHuman Otc Drug
Portfolio14 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 When Using This Product 📄 Keep Out of Reach of Children 📄 Other Information 📄 Questions or Comments 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 73 words ▾

Uses ■ (for step 1) Antiseptic to decrease bacteria on the skin ■ (for step 2) For the removal of common warts. The common wart is easily recognized by the rough “cauliflower-like” appearance of the surface ■ For the removal of plantar warts on the bottom of the foot. The plantar wart is recognized by its location only on the bottom of the foot, its tenderness, and the interruption of the footprint pattern

⏱️ Dosage and Administration 67 words ▾

Directions ■ (for step 1) Wash the affected area with one or two drops ■ ( for step 2) Clean using step 1 and allow area to dry. Apply a small amount at a time with applicator to sufficiently cover each wart and let dry ■ Let dry ■ Repeat this procedure once or twice daily as needed (until wart is removed) for up to 12 weeks

⚠️ Warnings 19 words ▾

Warnings - For external use only (for step 1 & 2) Extremely flammable. Keep away from fire or flames

🧪 Active Ingredient 19 words ▾

Drug Facts Active Ingredient (in step 1) ...................... Alcohol 60% Active Ingredient (in step 2) ............. Salicylic Acid 17%

🧪 Inactive Ingredients 34 words ▾

Inactive Ingredients (for step 1) Glycerin, Hydroxypropyl Cellulose, Lavandula Angustifolia (Lavender) Flower Extract, Purified Water (for step 2) Alcohol (Ethanol), Artemisia Absinthium (Wormwood) Extract, Carica Papaya (Papaya) Fruit Extract, Glycerin, Hydroxypropyl Cellulose, Purified Water

🎯 Purpose 15 words ▾

Purpose Alcohol 60% (step 1) ............................................................... Antiseptic Salicylic Acid 17% (step 2) ................................................ Wart Remover

📄 When Using This Product 57 words ▾

When using step 2 , do not use: on irritated skin, any area that is infected or reddened, if you are diabetic, have poor blood circulation, moles, birthmarks, genital warts, warts with hair growing from them, warts on the face, or mucous membranes If swallowed, get medical help or contact a poison control center right away 1-800-222-1222

📄 Keep Out of Reach of Children 86 words ▾

Keep out of reach of children. Stop use and consult a doctor if discomfort persists. Avoid contact with the eyes.

If contact with eye occurs, wash thoroughly with water When using step 2 , do not use: on irritated skin, any area that is infected or reddened, if you are diabetic, have poor blood circulation, moles, birthmarks, genital warts, warts with hair growing from them, warts on the face, or mucous membranes If swallowed, get medical help or contact a poison control center right away 1-800-222-1222

📄 Other Information 8 words ▾

Other Information Store at room temperature: 20-27ºC (68-81ºF)

📄 Questions or Comments 14 words ▾

Questions or Comments? 800.307.8818 | BlaineLabs.com M-F, 7:30 AM - 4:00 PM (pst) [email protected]

📄 Package Label / Principal Display Panel 68 words ▾

VERUCIDE ® Wart Remover Kit Labeling BLAINE LABS ` NDC 63347-720-01 VERUCIDE ® WART REMOVER TWO-STEP WART TREATMENT KIT SALICYLIC ACID IN A SOLUTION CONTAINING ALCOHOL AND PAPAYA EXTRACT KIT INCLUDES: STEP 1: 0.253 FL OZ (7.5 mL) STEP 2: 0.101 FL OZ (3.0 mL) Manufactured By: Blaine Labs, Inc. 11037 Lockport Place Santa Fe Springs, CA 90670 Step1 Step2 res Verucide 750 Kit 721 Step1 722 Step2

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for VERUCIDE WART REMOVER Kit (this brand).

Top reported reactions

Amnesia1
Apathy1
Aphasia1
Asthenia1
Chest Discomfort1
Condition Aggravated1
Decreased Interest1

Reporter sex

3 reports
Male · 33%
Female · 67%

Serious outcomes

Life-threatening1
Reports over time (by year) — tap or hover for the count & year
2022 2023 2024 2026 1 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

About this NDC listing & data coverage

Over-the-counter (OTC) product Kit / multi-component package

Kit / multi-component package

This NDC identifies a kit — a package containing more than one component. Structured data (pricing, ingredients, equivalents) is often reported per component rather than for the kit NDC itself, which can make this page look thinner than the components' own pages.

What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos — Not published for this NDC No photo available yet for this listing.
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Blaine Labs Inc.. Listing status can change — the directory data on this page refreshes weekly.
Who lists this product with the FDA?
Blaine Labs Inc. is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 63347-0601-01 · Blaine 63347-0800-01 · Blaine →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.